Review article: the management of severe ulcerative colitis. by Hyde, G, Jewell, D

Histological changes associated with the use of intravenous cyclosporin in the treatment of severe ulcerative colitis may mimic dysplasia. by Hyde, G, Jewell, D, Warren, B

Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? by Hyde, G, Thillainayagam, A, Jewell, D

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. by Hyde, G, Jewell, D, Kettlewell, MG, Mortensen, N

A survey of frequent attenders at a gastroenterology clinic. by Bass, C, Hyde, G, Bond, A, Sharpe, M

HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. by Roskell, D, Hyde, G, Campbell, A, Jewell, D, Gray, W

POLY(ADP-RIBOSE) POLYMERASE-14 INTERACTS WITH TRISTETRAPROLIN TO SELECTIVELY REGULATE TISSUE FACTOR MRNA STABILITY: A NOVEL ROLE FOR ADP-RIBOSYLATION IN REGULATING MRNA TURNOVER AN... by Iqbal, M, Johns, M, Yu, S, Hyde, G, Laffan, M, Gavins, F, Blackshear, P, Dean, J, Mackman, N, Boothby, M, Haskard, DO

PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression. by Iqbal, M, Johns, M, Cao, J, Liu, Y, Yu, S, Hyde, G, Laffan, M, Marchese, F, Cho, S, Clark, A, Gavins, F, Woollard, K, Blackshear, P, Mackman, N, Dean, J, Boothby, M, Haskard, DO